Search Results - "BURNSIDE, MERCEDES J."

Extended Use of an Open-Source Automated Insulin Delivery System in Children and Adults with Type 1 Diabetes: The 24-Week Continuation Phase Following the CREATE Randomized Controlled Trial by Burnside, Mercedes J, Lewis, Dana M, Crocket, Hamish R, Meier, Renee A, Williman, Jonathan A, Sanders, Olivia J, Jefferies, Craig A, Faherty, Ann M, Paul, Ryan G, Lever, Claire S, Price, Sarah K J, Frewen, Carla M, Jones, Shirley D, Gunn, Tim C, Lampey, Christina, Wheeler, Benjamin J, de Bock, Martin I

“…To assess long-term efficacy and safety of open-source automated insulin delivery (AID) in children and adults (7-70 years) with type 1 diabetes. Both arms of…”
Get more information

Open-Source Automated Insulin Delivery in Type 1 Diabetes by Burnside, Mercedes J., Lewis, Dana M., Crocket, Hamish R., Meier, Renee A., Williman, Jonathan A., Sanders, Olivia J., Jefferies, Craig A., Faherty, Ann M., Paul, Ryan G., Lever, Claire S., Price, Sarah K.J., Frewen, Carla M., Jones, Shirley D., Gunn, Tim C., Lampey, Christina, Wheeler, Benjamin J., de Bock, Martin I.

“…In this randomized trial, an open-source automated insulin delivery system controlled glucose time-in-range values significantly better than sensor-augmented…”
Get full text

286-OR: The CREATE Trial: Randomized Clinical Trial Comparing Open-Source Automated Insulin Delivery with Sensor Augmented Pump Therapy in Type 1 Diabetes by BURNSIDE, MERCEDES J., LEWIS, DANA M., CROCKET, HAMISH, MEIER, RENEE, WILLIMAN, JONATHAN, SANDERS, OLIVIA J., JEFFERIES, CRAIG A., FAHERTY, ANN M., PAUL, RYAN, LEVER, CLAIRE S., WHEELER, BENJAMIN J., JONES, SHIRLEY, FREWEN, CARLA M., GUNN, TIM, LAMPEY, CHRISTINA, DE BOCK, MARTIN

“…Objective: Open-source automated insulin delivery (AID) pre-dated the availability of commercial systems and is used by thousands of people with T1D despite no…”
Get full text

Inequity in access to continuous glucose monitoring and health outcomes in paediatric diabetes, a case for national continuous glucose monitoring funding: a cross-sectional population study of children with type 1 diabetes in New Zealand by Burnside, Mercedes J., Williman, Jonathan A., Davies, Hannah M., Jefferies, Craig A., Paul, Ryan G., Wheeler, Benjamin J., Wiltshire, Esko J., Anderson, Yvonne C., de Bock, Martin I.

“…Continuous glucose monitoring (CGM) improves glycaemia for people affected by type 1 diabetes (T1D), but is not funded in Aotearoa/New Zealand. This study…”
Get full text

Open-Source Automated Insulin Delivery in Type 1 Diabetes by Murata, Yuki, Takita, Morihito, Kami, Masahiro, Scaramuzza, Andrea E., Cherubini, Valentino, Rabbone, Ivana, Burnside, Mercedes J., Williman, Jonathan A., de Bock, Martin I.

“…To the Editor: Burnside et al. (Sept. 8 issue) 1 report the superiority of an open-source automated insulin delivery (AID) system over a commercial…”
Get full text

Open-Source Automated Insulin Delivery in Type 1 Diabetes. Reply by Burnside, Mercedes J, Williman, Jonathan A, de Bock, Martin I

Get full text

Inequity in access to continuous glucose monitoring and health outcomes in paediatric diabetes, a case for national continuous glucose monitoring funding: A cross-sectional population study of children with type 1 diabetes in New ZealandResearch in context by Mercedes J. Burnside, Jonathan A. Williman, Hannah M. Davies, Craig A. Jefferies, Ryan G. Paul, Benjamin J. Wheeler, Esko J. Wiltshire, Yvonne C. Anderson, Martin I. de Bock

“…Background: Continuous glucose monitoring (CGM) improves glycaemia for people affected by type 1 diabetes (T1D), but is not funded in Aotearoa/New Zealand…”
Get full text